See why ketamine boosts outcomes for treatment‑resistant depression.
Ben Yudkoff, MD
Advertisement
Articles by Ben Yudkoff, MD
Discover more on the uses and context of ketamine.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
Adjunctive Atypical Antipsychotics in Major Depressive Disorder: Comparing Efficacy and Tolerability
4
New Name, New Path for Psychiatry: The Future of the DSM
5